Lung-cancer staging with PET-CT [4]

New England Journal of Medicine

Volumn 361, Issue 16, 2009, Pages 1607-

  Kloecker, Goetz ^a   Civelek, Cahid ^a   Janjua, Mohammad ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LETTER; LUNG CANCER; LYMPH NODE METASTASIS; MEDIASTINOSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORACOTOMY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; NOTE; PREOPERATIVE CARE; SENSITIVITY AND SPECIFICITY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MEDIASTINOSCOPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350518855     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Nambu A, Kato S, Sato Y, et al. Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET. Ann Nucl Med 2009;23:269-275
2. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002;359:1388-1393
3. Serra M, Cirera L, Rami-Porta R, et al. Routine positron emission tomography (PET) and selective mediastinoscopy is as good as routine mediastinoscopy to rule out N2 disease in nonsmall cell lung cancer (NSCLC). J Clin Oncol 2006;24:Suppl:18S. abstract.
4. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:Suppl:202S-220S. (Pubitemid 47502808)